The pro-apoptotic Ras effector Nore1 may serve as a Ras-regulated tumor suppressor in the lung

被引:99
作者
Vos, MD [1 ]
Martinez, A [1 ]
Ellis, CA [1 ]
Vallecorsa, T [1 ]
Clark, GJ [1 ]
机构
[1] NCI, Dept Cell & Canc Biol, NIH, Rockville, MD 20850 USA
关键词
D O I
10.1074/jbc.M211019200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Ras oncoproteins mediate multiple biological effects by activating multiple effectors. Classically, Ras activation has been associated with enhanced cellular growth and transformation. However, activated forms of Ras may also inhibit growth by inducing senescence, apoptosis, and differentiation. Induction of apoptosis by Ras may be mediated by its effector RASSF1, which appears to function as a tumor suppressor. We now show that the Ras effector Nore1, which is structurally related to RASSF1, can also mediate a Ras-dependent apoptosis. Moreover, an analysis of Nore1 protein expression showed that it is frequently down-regulated in lung tumor cell lines and primary lung tumors. Like RASSF1, this correlates with methylation of the Nore1 promoter rather than gene deletion. Finally, re- introduction of Nore1, driven by its own promoter, impairs the growth in soft agar of a human lung tumor cell line. Consequently, we propose that the Ras effector Nore1 is a member of a family of Ras effector/tumor suppressors that includes RASSF1.
引用
收藏
页码:21938 / 21943
页数:6
相关论文
共 45 条
  • [1] Methylation associated inactivation of RASSF1A from region 3p21.3 in lung, breast and ovarian tumours
    Agathanggelou, A
    Honorio, S
    Macartney, DP
    Martinez, A
    Dallol, A
    Radar, J
    Fullwood, P
    Chauhan, A
    Walker, R
    Shaw, JA
    Hosoe, S
    Lerman, MI
    Minna, JD
    Maher, ER
    Latif, F
    [J]. ONCOGENE, 2001, 20 (12) : 1509 - 1518
  • [2] REVERSIBLE ABROGATION OF IL-3 DEPENDENCE BY AN INDUCIBLE H-RAS ONCOGENE
    ANDREJAUSKAS, E
    MORONI, C
    [J]. EMBO JOURNAL, 1989, 8 (09) : 2575 - 2581
  • [3] MICROINJECTION OF THE RAS ONCOGENE PROTEIN INTO PC12 CELLS INDUCES MORPHOLOGICAL-DIFFERENTIATION
    BARSAGI, D
    FERAMISCO, JR
    [J]. CELL, 1985, 42 (03) : 841 - 848
  • [4] PROTEINS REGULATING RAS AND ITS RELATIVES
    BOGUSKI, MS
    MCCORMICK, F
    [J]. NATURE, 1993, 366 (6456) : 643 - 654
  • [5] BOLLAG G, 1992, CANCER BIOL, V3, P199
  • [6] Epigenetic inactivation of RASSF14 in lung and breast cancers and malignant phenotype suppression
    Burbee, DG
    Forgacs, E
    Zöchbauer-Müller, S
    Shivakumar, L
    Fong, K
    Gao, BN
    Randle, D
    Kondo, M
    Virmani, A
    Bader, S
    Sekido, Y
    Latif, F
    Milchgrub, S
    Toyooka, S
    Gazdar, AF
    Lerman, MI
    Zabarovsky, E
    White, M
    Minna, JD
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2001, 93 (09): : 691 - 699
  • [7] Increasing complexity of Ras signaling
    Campbell, SL
    Khosravi-Far, R
    Rossman, KL
    Clark, GJ
    Der, CJ
    [J]. ONCOGENE, 1998, 17 (11) : 1395 - 1413
  • [8] CHEN CY, 1995, ONCOGENE, V11, P1487
  • [9] Oncogenic Ras triggers cell suicide through the activation of a caspase-independent cell death program in human cancer cells
    Chi, SJ
    Kitanaka, C
    Noguchi, K
    Mochizuki, T
    Nagashima, Y
    Shirouzu, M
    Fujita, H
    Yoshida, M
    Chen, WB
    Asai, A
    Himeno, M
    Yokoyama, S
    Kuchino, Y
    [J]. ONCOGENE, 1999, 18 (13) : 2281 - 2290
  • [10] Clark G. J., 1993, GTPASES BIOL, DOI [10.1007/978-3-642-78267-1_18, DOI 10.1007/978-3-642-78267-1_18]